<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83324-330-01
</NDCCode>
<PackageDescription>
1 TUBE in 1 BOX (83324-330-01) / 25.5 g in 1 TUBE
</PackageDescription>
<NDC11Code>
83324-0330-01
</NDC11Code>
<ProductNDC>
83324-330
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Maximum Strength Hemorrhoidal Cream With Aloe
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Glycerin, Phenylephine Hci, Pramoxine Hci, Petrolatum
</NonProprietaryName>
<DosageFormName>
CREAM
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20250708
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M015
</ApplicationNumber>
<LabelerName>
Chain Drug Marketing Association
</LabelerName>
<SubstanceName>
GLYCERIN; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE; WHITE PETROLATUM
</SubstanceName>
<StrengthNumber>
14.4; .25; 1; 15
</StrengthNumber>
<StrengthUnit>
g/100g; g/100g; g/100g; g/100g
</StrengthUnit>
<Pharm_Classes>
Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-07-11
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250708
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>